Get started
Author

Juan José Corte

Observed names: J.J. Corte, Juan Carlos Gainzarain, Juan José Corte-García
ORCID: 0009-0000-0279-2281
Observed ORCID: 0009-0000-0279-2281
OpenAlex ID: A5120083354
Impact of computerized physician order entry on medication errors
2012 · M.D. Menendez, J. Alonso, et al. · Revista de Calidad Asistencial · 18
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)
2025 · Luis Buzón-Martín, Maria Luisa Montes, et al. · Journal of Antimicrobial Chemotherapy · 15
La farmacia hospitalaria rumbo al 2030
2024 · Edurne Fernández de Gamarra-Martínez, Begoña Tortajada-Goitia, et al. · Farmacia Hospitalaria · 13
Long‐acting cabotegravir and rilpivirine in people with HIV and obesity: Real‐world outcomes from the RELATIVITY cohort
2026 · Jesús Troya, Rafael Mican, et al. · HIV Medicine · 4
PDF
Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real‐world data from the Spanish RELATIVITY cohort
2025 · Jesús Troya, María Luisa Montes, et al. · HIV Medicine · 4
PDF
[Translated article] Hospital pharmacy towards 2030
2024 · Edurne Fernández de Gamarra-Martínez, Begoña Tortajada-Goitia, et al. · Farmacia Hospitalaria · 2
Long-term Effectiveness, Treatment Persistence, and Timing of Virological Failure With Long-Acting Cabotegravir Plus Rilpivirine in Real-World HIV Care: RELATIVITY Cohort
2026 · Luis Buzón, Noemí Cabello-Clotet, et al. · Open Forum Infectious Diseases
PDF
P-358. Long-Acting Cabotegravir and Rilpivirine in People Living with HIV and Obesity: Real-World Insights from the RELATIVITY Cohort
2026 · Jesús Troya, Rafael Micán, et al. · Open Forum Infectious Diseases
393. Long-Acting Injectable Cabotegravir and Rilpivirine in the Aging HIV Population: Insights from the RELATIVITY Cohort
2026 · Jesús Troya, Carmen Busca, et al. · Open Forum Infectious Diseases
Works count: 10
Citation count: 56
H-index: 4
I10-index: 3
Year
Topic
Type